Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of chimeric antigen receptor-modified T-cells to treat cancer

Use of chimeric antigen receptor-modified T-cells to treat cancer

US Patent 9499629 · Granted Nov 22, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Chimeric antigen receptor T regulatory cells for the treatment of atherosclerosi2025
Methods of treating cancer using anti-CD137 antibodies2025
Switch costimulatory receptors2025
Compositions and methods for generating a persisting population of T cells usefu2025
CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric a2025
Altering gene expression in cart cells and uses thereof2025
Use of trans-signaling approach in chimeric antigen receptors2025
Methods for improving the efficacy and expansion of immune cells2025
Methods for improving the efficacy and expansion of immune cells2025
Methods for improving the efficacy and expansion of immune cells2025
Use of the CD2 signaling domain in second-generation chimeric antigen receptors2025
Use of CD2/5/7 knock-out anti-CD2/5/7 chimeric antigen receptor T cells against 2025